The Impact of COVID-19 Infection on Multiple Sclerosis Disease Course Across 12 Countries: a Propensity-Score-matched Cohort Study
David Levitz, Yi Chao Foong,Paul Sanfilippo, Tim Spelman,Louise Rath, Angie Roldan, Anoushka Lal,Mastura Monif,Vilija Jokubaitis, Serkan Ozakbas, Raed Alroughani, Cavit Boz,Murat Terzi,Tomas Kalincik, Yolanda Blanco, Matteo Foschi, Andrea Surcinelli, Katherine Buzzard, Olga Skibina, Guy Laureys, Liesbeth Van Hijfte, Cristina Ramo-Tello,Aysun Soysal, Jose Luis Sanchez-Menoyo, Mario Habek, Elisabetta Cartechini, Juan Ignacio Rojas, Rana Karabudak, Barbara Willekens, Talal Al-Harbi, Yara Fragoso, Tamara Castillo-Triviño, Danny Decoo, Maria Cecilia Aragon de Vecino, Eli Skromne, Carmen-Adella Sirbu,Chao Zhu,Daniel Merlo,Melissa Gresle,Helmut Butzkueven,Anneke Van Der Walt Therapeutic advances in neurological disorders（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper